Clinical progress note: Hepatitis B
Journal of Hospital Medicine · 15.08.2026
DOI: 10.1002/jhm.70424 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hospital Medicine, online erschienen am 15.08.2026. Verfasst von Yarlini Vipulanandan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA. Die Arbeit nennt 16 Literaturangaben. Gefördert von: None.
Abstract (Originalsprache)
Hepatitis B virus is a well‐known infectious etiology of acute and chronic liver disease worldwide. Notably, 90% of children infected with hepatitis B in infancy develop chronic infection and subsequent progressive liver disease, including cirrhosis and hepatocellular carcinoma. Significant reduction in perinatal transmission in the United States (US) was seen after implementation of universal infant vaccination 30 years ago, as well as dramatic reductions in HBV incidence across Asia, coinciding with widespread hepatitis B vaccination. However, with ongoing changes to federal vaccine guidance and a steady rise in vaccine hesitancy, a comprehensive understanding of the epidemiology, transmission, screening, and prevention of hepatitis B remains important for pediatric health care providers.
Autor:innen und Institutionen
- Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
ORCID-Profile: Yarlini Vipulanandan
Förderung
- None
Zitieren
APA
Vipulanandan, Y., & Poole, C. (2026). Clinical progress note: Hepatitis B. Journal of Hospital Medicine. https://doi.org/10.1002/jhm.70424
Vancouver
Vipulanandan Y, Poole C. Clinical progress note: Hepatitis B. Journal of Hospital Medicine. 2026. doi:10.1002/jhm.70424
BibTeX
@article{Vipulanandan2026,
author = {Vipulanandan, Yarlini and Poole, Claudette},
title = {Clinical progress note: Hepatitis B},
journal = {Journal of Hospital Medicine},
year = {2026},
doi = {10.1002/jhm.70424}
}
EUVIMED